Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | SOS2 |
| Upstream (Parents) |
|---|
| (<<) ACTN4 → SOS2 |
| (<<) ATF2 → SOS2 |
| (<<) CAT → SOS2 |
| (<<) DHX9 → SOS2 |
| (<<) ELF2 → SOS2 |
| (<<) HGS → SOS2 |
| (<<) MAP3K2 → SOS2 |
| (<<) NFKBIB → SOS2 |
| (<<) RAB5A → SOS2 |
| (<<) YWHAB → SOS2 |
| Downstream (Children) |
|---|
| SOS2 → CRKL (>>) |
| SOS2 → CTNNB1 (>>) |
| SOS2 → IL1F5 (>>) |
| SOS2 → KRT16 (>>) |
| SOS2 → MAP2K4 (>>) |
| SOS2 → MTMR6 (>>) |
| SOS2 → NPAS3 (>>) |
| SOS2 → PIK3CB (>>) |
| SOS2 → PLCH2 (>>) |
| SOS2 → RB1 (>>) |
| SOS2 → RNASE4 (>>) |
| SOS2 → RYK (>>) |
| SOS2 → SMAD2 (>>) |
| SOS2 → SMAD5 (>>) |
| SOS2 → TP53 (>>) |
